PENWEST PHARMACEUTICALS CO (PPCO) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 276 transactions totaling $27.2M, demonstrating a bullish sentiment with $19.9M in net insider flow. The most recent transaction on Nov 4, 2010 involved a purchase of 3,173,334 shares valued at $0.
No significant insider buying has been recorded for PPCO in the recent period.
No significant insider selling has been recorded for PPCO in the recent period.
Based on recent SEC filings, insider sentiment for PPCO is bullish with an Insider Alignment Score of 87/100 and a net flow of $19.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at PENWEST PHARMACEUTICALS CO (PPCO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading PPCO stock, having executed 276 transactions in the past 90 days. The most active insider is Life Sciences Master Fund Ltd Perceptive (Executive), who has made 7 transactions totaling $33.8M.
Get notified when executives and directors at PPCO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 4, 2010 | Corp. West Acquisition | Executive | Purchase | 3,173,334 | $N/A | $0 | |
| Sep 20, 2010 | Baichwal Anand | Executive | Tender | 27,930 | $N/A | $0 | |
| Sep 20, 2010 | F. Drake Peter | Executive | Tender | 100,263 | $N/A | $0 | |
| Sep 20, 2010 | L. Good Jennifer | Executive | Tender | 60,994 | $N/A | $0 | |
| Sep 20, 2010 | Hawi Amale | Executive | Tender | 6,500 | $N/A | $0 | |
| Sep 20, 2010 | P. Meeker David | Executive | Tender | 38,358 | $N/A | $0 | |
| Sep 20, 2010 | P. Muscolo Frank | Executive | Tender | 3,513 | $N/A | $0 | |
| Sep 20, 2010 | Wong Roderick | Executive | Tender | 20,000 | $N/A | $0 | |
| Sep 20, 2010 | Zarrabian Saiid | Executive | Tender | 20,000 | $N/A | $0 | |
| Sep 20, 2010 | Vanlent Anne | Executive | Tender | 50,491 | $N/A | $0 | |
| Sep 20, 2010 | Sciascia Thomas | Executive | Tender | 40,494 | $N/A | $0 | |
| Sep 20, 2010 | Management Llc Tang Capital | Executive | Tender | 225,000 | $5.00 | $1.1M | Large |
| Sep 20, 2010 | Management Llc Tang Capital | Executive | Tender | 6,396,598 | $5.00 | $32.0M | Large |
| Sep 20, 2010 | Sciences Master Fund Ltd Perceptive Life | Executive | Tender | 6,476,446 | $5.00 | $32.4M | Large |
| Jun 30, 2010 | Wong Roderick | Executive | Award | 20,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 13 | $65.5M | 68.5% |
Purchase(P) | 51 | $23.6M | 24.7% |
Sale(S) | 21 | $3.6M | 3.8% |
Exercise(M) | 19 | $1.7M | 1.8% |
Other(J) | 3 | $695.4K | 0.7% |
Disposition(D) | 13 | $362.3K | 0.4% |
Award(A) | 155 | $68.6K | 0.1% |
Discretionary(I) | 1 | $18.2K | 0.0% |
Insiders at PENWEST PHARMACEUTICALS CO are accumulating shares at an accelerated pace. With 26 insiders making 276 transactions totaling $23.6M in purchases versus $3.6M in sales, the net buying activity of $19.9M signals strong executive confidence. Life Sciences Master Fund Ltd Perceptive (Executive) leads the buying activity with $33.8M in transactions across all time.